Aeva Reports Third Quarter 2021 Results

Aeva-Logo-Blue

Continued momentum in automotive, with Plus production win to implement Aeva’s 4D LiDAR on PlusDrive autonomous trucks

Selected Fabrinet for automotive-grade production of 4D LiDAR chip module

On track to complete B sample development by year end and deliveries to our partners in 2022

MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–Aeva (NYSE: AEVA), a leader in next-generation sensing and perception systems, today announced its third quarter 2021 results.

Key Company Highlights

  • Key production win with Plus to implement Aeva’s 4D LiDAR as long-range LiDAR on PlusDrive autonomous trucks
  • On track with key development milestones across other automotive and non-automotive collaborations
  • Selected Fabrinet as automotive-grade manufacturing partner (IATF 16949 certified) to produce 4D LiDAR chip module and accelerate manufacturing capabilities
  • Completed product design release for B sample, providing path to final cost structure and deliveries to our partners in 2022

Aeva is solidifying the path to commercialization of our breakthrough 4D LiDAR,” said Soroush Salehian, Co-Founder and CEO at Aeva. “The production win with Plus is significant because it highlights our growing commercial momentum as the industry increasingly transitions to FMCW LiDAR to enable safe automated driving, and it validates the leading performance and scalability of Aeva’s automotive-grade LiDAR on chip technology. We remain laser focused on supporting our partners and working towards realizing Aeva’s mission to bring perception to all devices.”

Third Quarter 2021 Financial Highlights

  • Cash, Cash Equivalents and Marketable Securities
  • Cash, cash equivalents and marketable securities of $477.7 million as of September 30, 2021
  • Revenue
    • Revenue of $3.5 million in Q3 2021, compared to $1.9 million in Q3 2020
  • GAAP and Non-GAAP Operating Loss*
    • GAAP operating loss of $27.4 million in Q3 2021, compared to GAAP operating loss of $4.8 million in Q3 2020
    • Non-GAAP operating loss of $19.9 million in Q3 2021, compared to non-GAAP operating loss of $3.7 million in Q3 2020
  • GAAP and Non-GAAP Net Loss per Share*
    • GAAP net loss per share of $0.13 in Q3 2021, compared to GAAP net loss per share of $0.03 in Q3 2020
    • Non-GAAP net loss per share of $0.09 in Q3 2021, compared to non-GAAP net loss per share of $0.02 in Q3 2020
  • Shares Outstanding
    • Weighted average shares outstanding of 212.6 million in Q3 2021
  • *Tables reconciling GAAP to Non-GAAP measures are provided at the end of this release.

    2021 Objectives

    Aeva has already achieved three of the four objectives for 2021 and is on track to deliver the final objective. Our 2021 objectives are summarized below:

    • Build on momentum with two additional programs towards production: Completed goal with Plus and Nikon collaborations; remain on track with other collaborations
    • Accelerate engagements in non-automotive applications: Completed goal with Nikon collaboration for industrial metrology and automation
    • Strengthen supply chain for production to bring Aeva 4D LiDAR to scale: Completed goal with a number of key developments including finalizing key supply chain for our silicon processing chip and selecting Fabrinet to produce our 4D LiDAR chip module
    • Complete next-generation B sample development: On track to finish by year end and working with supply chain to prepare for deliveries in 2022

    Conference Call Details

    The company will host a conference call and live webcast to discuss results at 2:00 p.m. PT / 5:00 p.m. ET today. The live webcast and replay can be accessed at investors.aeva.ai.

    About Aeva Technologies, Inc. (NYSE: AEVA)

    Founded in 2017 by former Apple engineers Soroush Salehian and Mina Rezk, and led by a multidisciplinary team of engineers and operators experienced in the field of sensing and perception, Aeva’s mission is to bring the next wave of perception technology to broad applications from automated driving to consumer electronics, consumer health, industrial robotics, and security. For more information, visit www.aeva.com.

    Aeva®, the Aeva logo and 4D LiDAR are trademarks/registered trademarks of Aeva, Inc. All rights reserved. Third-party trademarks are the property of their respective owners.

    Forward looking statements

    This press release contains certain forward-looking statements within the meaning of the federal securities laws. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Forward looking statements in this press release include our beliefs regarding our financial position and operating performance for the third quarter of 2021 and business objectives for 2021, along with our expectations with respect to our collaborations with third parties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including, but not limited to: (i) the ability to maintain the listing of Aeva’s securities on the New York Stock Exchange, (ii) the price of Aeva’s securities, which may be volatile due to a variety of factors, including changes in the competitive and highly regulated industries in which Aeva plans to operate, variations in performance across competitors, changes in laws and regulations affecting Aeva’s business and changes in the combined capital structure, (iii) the ability to implement business plans, forecasts, and other expectations and to identify and realize additional opportunities, (iv) the risk of downturns and the possibility of rapid change in the highly competitive industry in which Aeva operates, (v) the risk that Aeva and its current and future collaborators are unable to successfully develop and commercialize Aeva’s products or services, or experience significant delays in doing so, (vi) the risk that Aeva may never achieve or sustain profitability; (vii) the risk that Aeva will need to raise additional capital to execute its business plan, which many not be available on acceptable terms or at all; (viii) the risk that Aeva experiences difficulties in managing its growth and expanding operations, (ix) the risk that third-parties suppliers and manufacturers are not able to fully and timely meet their obligations, (x) the risk of product liability or regulatory lawsuits or proceedings relating to Aeva’s products and services, (xi) the risk that Aeva is unable to secure or protect its intellectual property; and (xii) the effects of the ongoing coronavirus (COVID-19) pandemic or other infectious diseases, health epidemics, pandemics and natural disasters on Aeva’s business. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors, and for a further discussion of the material risks and other important factors that could affect our financial results, please refer to our filings with the SEC, including our Form 10-Q for the quarter ended June 30, 2021. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Aeva assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Aeva does not give any assurance that it will achieve its expectations.

    AEVA TECHNOLOGIES, INC.

    Condensed Consolidated Balance Sheet

    (Unaudited)

    (In thousands)

     

     

     

     

     

     

     

    September 30,

    2021

     

    December 31,

    2020

     

     

     

     

     

    ASSETS

     

     

     

     

    CURRENT ASSETS:

     

     

     

     

    Cash and cash equivalents

     

    $

    107,456

     

     

    $

    24,624

     

    Marketable securities

     

     

    370,214

     

     

     

     

    Accounts receivable, net

     

     

    1,213

     

     

     

    141

     

    Inventory

     

     

    3,337

     

     

     

    1,219

     

    Other current assets

     

     

    8,457

     

     

     

    4,970

     

    Total current assets

     

     

    490,677

     

     

     

    30,954

     

    Operating lease right-of-use assets

     

     

    10,981

     

     

     

     

    Property and equipment, net

     

     

    3,755

     

     

     

    1,614

     

    Other assets

     

     

    855

     

     

     

    64

     

    TOTAL ASSETS

     

    $

    506,268

     

     

    $

    32,632

     

    LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY

     

     

     

     

    CURRENT LIABILITIES:

     

     

     

     

    Accounts payable

     

    $

    5,156

     

     

    $

    2,071

     

    Accrued liabilities

     

     

    3,987

     

     

     

    2,606

     

    Accrued employee costs

     

     

    2,335

     

     

     

    722

     

    Lease liability, current portion

     

     

    2,816

     

     

     

     

    Other current liabilities

     

     

    522

     

     

     

    275

     

    Total current liabilities

     

     

    14,816

     

     

     

    5,674

     

    Lease liability, noncurrent portion

     

     

    8,194

     

     

     

     

    Warrant liability

     

     

    1,110

     

     

     

     

    Other liabilities

     

     

     

     

     

    45

     

    TOTAL LIABILITIES

     

     

    24,120

     

     

     

    5,719

     

    STOCKHOLDERS’ EQUITY:

     

     

     

     

    Common stock

     

     

    21

     

     

     

    15

     

    Additional paid-in capital

     

     

    613,428

     

     

     

    87,982

     

    Accumulated other comprehensive loss

     

     

    (81

    )

     

     

     

    Accumulated deficit

     

     

    (131,220

    )

     

     

    (61,084

    )

    TOTAL STOCKHOLDERS’ EQUITY

     

     

    482,148

     

     

     

    26,913

     

    TOTAL LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY

     

    $

    506,268

     

     

    $

    32,632

     

    AEVA TECHNOLOGIES, INC.

     

    Condensed Consolidated Statements of Operations

     

    (Unaudited)

     

    (In thousands, except share and per share data)

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended September 30,

     

     

    Nine Months Ended September 30,

     

     

     

    2021

     

     

    2020

     

     

    2021

     

     

    2020

     

    Revenue

     

    $

    3,483

     

     

    $

    1,945

     

     

    $

    6,392

     

     

    $

    4,111

     

    Cost of revenue (1)

     

     

    2,301

     

     

     

    986

     

     

     

    3,903

     

     

     

    2,191

     

    Gross profit

     

     

    1,182

     

     

     

    959

     

     

     

    2,489

     

     

     

    1,920

     

    Research and development expenses (1)

     

     

    20,908

     

     

     

    4,303

     

     

     

    51,019

     

     

     

    14,283

     

    General and administrative expenses (1)

     

     

    6,739

     

     

     

    1,208

     

     

     

    21,641

     

     

     

    3,339

     

    Selling and marketing expenses (1)

     

     

    922

     

     

     

    203

     

     

     

    2,079

     

     

     

    1,027

     

    Total operating expenses

     

     

    28,569

     

     

     

    5,714

     

     

     

    74,739

     

     

     

    18,649

     

    Loss from operations

     

     

    (27,387

    )

     

     

    (4,755

    )

     

     

    (72,250

    )

     

     

    (16,729

    )

    Interest income

     

     

    119

     

     

     

    3

     

     

     

    228

     

     

     

    194

     

    Other expense, net

     

     

    663

     

     

     

    (2

    )

     

     

    1,886

     

     

     

    (22

    )

    Net loss before taxes

     

     

    (26,605

    )

     

     

    (4,754

    )

     

     

    (70,136

    )

     

     

    (16,557

    )

    Income tax provision

     

     

     

     

     

     

     

     

     

     

     

     

    Net loss

     

    $

    (26,605

    )

     

    $

    (4,754

    )

     

    $

    (70,136

    )

     

    $

    (16,557

    )

    Net loss per share, basic and diluted

     

    $

    (0.13

    )

     

    $

    (0.03

    )

     

    $

    (0.36

    )

     

    $

    (0.12

    )

    Shares used in computing net loss per share, basic and diluted

     

     

    212,587,878

     

     

     

    143,942,078

     

     

     

    196,302,040

     

     

     

    139,526,408

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    (1) Includes stock-based compensation as follows:

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended September 30,

     

     

    Nine Months Ended September 30,

     

     

     

    2021

     

     

    2020

     

     

    2021

     

     

    2020

     

    Cost of revenue

     

    $

    593

     

     

    $

    241

     

     

    $

    1,003

     

     

    $

    470

     

    Research and development expenses

     

     

    4,806

     

     

     

    388

     

     

     

    8,624

     

     

     

    1,255

     

    General and administrative expenses

     

     

    2,017

     

     

     

    367

     

     

     

    6,209

     

     

     

    1,070

     

    Selling and marketing expenses

     

     

    107

     

     

     

    13

     

     

     

    209

     

     

     

    20

     

    Total stock-based compensation expense

     

    $

    7,523

     

     

    $

    1,009

     

     

    $

    16,045

     

     

    $

    2,815

     

    Aeva Technologies, Inc.

     

    Statements of Cash Flows

     

    (Unaudited)

     

    (In thousands)

     

     

     

    Nine Months Ended September 30,

     

     

     

    2021

     

     

    2020

     

    Cash flows from operating activities:

     

     

     

     

     

     

    Net loss

     

    $

    (70,136

    )

     

    $

    (16,557

    )

    Adjustments to reconcile net loss to net cash used in operating activities:

     

     

     

     

     

     

    Depreciation

     

     

    741

     

     

     

    603

     

    Loss on write down of fixed assets

     

     

    52

     

     

     

     

    Amortization of right-of-use assets

     

     

    1,204

     

     

     

     

    Change in fair value of warrant liability

     

     

    (1,904

    )

     

     

     

    Stock-based compensation

     

     

    16,045

     

     

     

    2,815

     

    Amortization of premium on available-for-sale securities

     

     

    960

     

     

     

     

    Changes in operating assets and liabilities:

     

     

     

     

     

     

    Accounts receivable

     

     

    (1,072

    )

     

     

    369

     

    Inventories

     

     

    (2,118

    )

     

     

    (465

    )

    Other current assets

     

     

    (6,673

    )

     

     

    (1,421

    )

    Other noncurrent assets

     

     

    (791

    )

     

     

    (5

    )

    Accounts payable

     

     

    3,275

     

     

     

    (86

    )

    Accrued liabilities

     

     

    3,343

     

     

     

    (1

    )

    Accrued employee costs

     

     

    771

     

     

     

    105

     

    Lease liability

     

     

    (1,101

    )

     

     

     

    Other current liabilities

     

     

    247

     

     

     

    54

     

    Other noncurrent liabilities

     

     

     

     

     

    13

     

    Net cash used in operating activities

     

     

    (57,157

    )

     

     

    (14,576

    )

    Cash flows from investing activities:

     

     

     

     

     

     

    Purchase of property, plant and equipment

     

     

    (2,241

    )

     

     

    (726

    )

    Purchase of available-for-sale securities

     

     

    (454,357

    )

     

     

     

    Sale of available-for-sale securities

     

     

    20,122

     

     

     

     

    Proceeds from maturities of marketable securities

     

     

    62,980

     

     

     

     

    Net cash used in investing activities

     

     

    (373,496

    )

     

     

    (726

    )

    Cash flows from financing activities:

     

     

     

     

     

     

    Proceeds from business combination and private offering

     

     

    560,777

     

     

     

     

    Transaction costs related to business combination and private offering

     

     

    (47,487

    )

     

     

     

    Payments of taxes withheld on net settled vesting of restricted stock units

     

     

    (495

    )

     

     

     

    Proceeds from exercise of stock options

     

     

    690

     

     

     

    37

     

    Net cash provided by financing activities

     

     

    513,485

     

     

     

    37

     

    Net increase (decrease) in cash and cash equivalents

     

     

    82,832

     

     

     

    (15,265

    )

    Beginning cash and cash equivalents

     

     

    24,624

     

     

     

    46,637

     

    Ending cash and cash equivalents

     

    $

    107,456

     

     

    $

    31,372

     

    Aeva Technologies, Inc.

     

    Reconciliation of GAAP to Non-GAAP Operating Results

     

    (Unaudited)

     

    (In thousands, except share and per share data)

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Reconciliation from GAAP to non-GAAP operating loss

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended September 30,

     

     

    Nine Months Ended September 30,

     

     

     

    2021

     

     

    2020

     

     

    2021

     

     

    2020

     

    GAAP operating loss

     

    $

    (27,387

    )

     

    $

    (4,755

    )

     

    $

    (72,250

    )

     

    $

    (16,729

    )

    Stock-based compensation

     

     

    7,523

     

     

     

    1,009

     

     

     

    16,045

     

     

     

    2,815

     

    Non-GAAP operating loss

     

    $

    (19,864

    )

     

    $

    (3,746

    )

     

    $

    (56,205

    )

     

    $

    (13,914

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Reconciliation from GAAP to non-GAAP net loss

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended September 30,

     

     

    Nine Months Ended September 30,

     

     

     

    2021

     

     

    2020

     

     

    2021

     

     

    2020

     

    GAAP net loss

     

    $

    (26,605

    )

     

    $

    (4,754

    )

     

    $

    (70,136

    )

     

    $

    (16,557

    )

    Stock-based compensation

     

     

    7,523

     

     

     

    1,009

     

     

     

    16,045

     

     

     

    2,815

     

    Change in fair value of warrant liability

     

     

    (664

    )

     

     

     

     

     

    (1,904

    )

     

     

     

    Non-GAAP net loss

     

    $

    (19,746

    )

     

    $

    (3,745

    )

     

    $

    (55,995

    )

     

    $

    (13,742

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Reconciliation from GAAP to non-GAAP net loss per share

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended September 30,

     

     

    Nine Months Ended September 30,

     

     

     

    2021

     

     

    2020

     

     

    2021

     

     

    2020

     

    Shares used in computing GAAP net loss per share:

     

     

     

     

     

     

     

     

     

     

     

     

    Basic and diluted

     

     

    212,587,878

     

     

     

    143,942,078

     

     

     

    196,302,040

     

     

     

    139,526,408

     

    GAAP net loss per share

     

     

     

     

     

     

     

     

     

     

     

     

    Basic and diluted

     

    $

    (0.13

    )

     

    $

    (0.03

    )

     

    $

    (0.36

    )

     

    $

    (0.12

    )

    Stock-based compensation

     

     

    0.04

     

     

     

    0.01

     

     

     

    0.08

     

     

     

    0.02

     

    Change in fair value of warrant liability

     

     

    0.00

     

     

     

     

     

     

    (0.01

    )

     

     

     

    Non-GAAP net loss per share

     

     

     

     

     

     

     

     

     

     

     

     

    Basic and diluted

     

    $

    (0.09

    )

     

    $

    (0.02

    )

     

    $

    (0.29

    )

     

    $

    (0.10

    )

     

    Contacts

    Investors:

    Andrew Fung

    [email protected]

    Media:

    Michael Oldenburg

    [email protected]

    Page 1 of 1650
    Next Page